Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Clinical trial NCT06648200 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06648200
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extensive Stage Small Cell Lung Cancer Recurrent

Start date: 2024-11-01
Primary completion: 2030-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.